Search - tctmd.com

Displaying 1 - 20 of 47

Sort: Relevancy | Date

News Conference News TCT 2024

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Yael L. Maxwell

November 05, 2024

Presentation TCT 2024

TCT 1583: Successful Multidisciplinary Management of Late Presentation of HOCM With Severe Pumonary Hypertension With Multiple Interventional Techniques

Presenter: Sukhdeep Basra

October 30, 2024

Presentation TCT 2024

Case 2: TTVI in Pulmonary Hypertension – Where Do We Draw the Line for Interventional Treatment?

Presenter: Laura Davidson

October 29, 2024

Presentation TCT 2024

TCT 621: Up to 20 Years Follow-Up of Severe Pulmonary Artery Hypertension Percutaneous Mitral Balloon Commissurotomy Due to Rheumatic Mitral Valve Disease

Presenter: Rafael Meneguz-Moreno

October 28, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

Presentation TCT 2024

TCT 1164: Severe Pulmonary Hypertension in Rheumatic Mitral Stenosis Drastically Reduced by Percutaneous Mitral Comissurotomy

Presenter: Chala Oljira

October 28, 2024

Presentation TCT 2024

Impact of Pulmonary Hypertension on Outcomes After Transcatheter Tricuspid Valve Edge-to-Edge Repair: Insights Into the EuroTR Registry

Presenter: Lukas Stolz

October 27, 2024

News Conference News TCT 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

L.A. McKeown

October 27, 2023

Presentation TCT 2023

Topic 4: Pulmonary Hypertension and Device Choice

Presenter: Neil Fam

October 26, 2023

Presentation TCT 2023

TCT 149: Severe Pulmonary Artery Hypertension and Rheumatic Disease: Long-Term Follow-UP After Percutaneous Mitral Balloon Commissurotomy

Presenter: Rafael Alexandre Meneguz-Moreno

October 25, 2023

Presentation TCT 2023

TCT 300: Temporal Trends, Mortality and In-hospital Complications in Patients With Pulmonary Hypertension Undergoing Transcatheter Aortic Valve Replacement

Presenter: Tauseef Akhtar

October 24, 2023

Presentation TCT 2023

Pulmonary Artery Denervation for Group II Pulmonary Hypertension: Updates from Ongoing Clinical Trials in China

Presenter: ShaoLiang Chen

October 23, 2023

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

Presentation TCT 2021

TCT 105: Impact of pulmonary hypertension differentiation on the outcome of patients undergoing MitraClip® therapy

Presenter: Tobias Schmidt

November 05, 2021

News Conference News TCT 2020

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

Caitlin E. Cox

October 14, 2020

Presentation TCT 2020

TCT 496: Tricuspid Valve Geometrical and Functional Changes and Their Associations With Outcomes in Pulmonary Arterial Hypertension

Presenter: Nicholas Kassis

October 14, 2020

Presentation TCT 2020

TCT 361: Impact of Pulmonary Hypertension on MitraClip Short-Term Outcomes: Nationwide Representative Study

Presenter: Omar Abdelfattah

October 14, 2020

News Conference News TCT 2019

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

L.A. McKeown

October 09, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

Shelley Wood

September 28, 2019

Advertisement

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

TCT 1583: Successful Multidisciplinary Management of Late Presentation of HOCM With Severe Pumonary Hypertension With Multiple Interventional Techniques

Case 2: TTVI in Pulmonary Hypertension – Where Do We Draw the Line for Interventional Treatment?

TCT 621: Up to 20 Years Follow-Up of Severe Pulmonary Artery Hypertension Percutaneous Mitral Balloon Commissurotomy Due to Rheumatic Mitral Valve Disease

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

TCT 1164: Severe Pulmonary Hypertension in Rheumatic Mitral Stenosis Drastically Reduced by Percutaneous Mitral Comissurotomy

Impact of Pulmonary Hypertension on Outcomes After Transcatheter Tricuspid Valve Edge-to-Edge Repair: Insights Into the EuroTR Registry

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

Topic 4: Pulmonary Hypertension and Device Choice

TCT 149: Severe Pulmonary Artery Hypertension and Rheumatic Disease: Long-Term Follow-UP After Percutaneous Mitral Balloon Commissurotomy

TCT 300: Temporal Trends, Mortality and In-hospital Complications in Patients With Pulmonary Hypertension Undergoing Transcatheter Aortic Valve Replacement

Pulmonary Artery Denervation for Group II Pulmonary Hypertension: Updates from Ongoing Clinical Trials in China

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

New Faces, New Formats, New Tech: What to Expect From TCT 2022

TCT 105: Impact of pulmonary hypertension differentiation on the outcome of patients undergoing MitraClip® therapy

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

TCT 496: Tricuspid Valve Geometrical and Functional Changes and Their Associations With Outcomes in Pulmonary Arterial Hypertension

TCT 361: Impact of Pulmonary Hypertension on MitraClip Short-Term Outcomes: Nationwide Representative Study

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content